long term safety of glp-1 drugs have taken the world by storm, helping many people lose 11%–16% their body weight. But a new Cochrane review reveals something surprising: the evidence supporting these blockbuster injections isn't glp-1 long-term use safety Considering

Simulations predicted that for a compound with a human PCSK9 affinity below 1 nM, a once-weekly 50 mg dose would achieve robust free PCSK9 suppression (Supplementary Fig

Options may include laser therapies, water-vapor treatments, image-guided procedures that remove excess prostate tissue, procedures that gently widen the urinary channel, or robotic-assisted surgery for larger prostates

Restored desire PT-141 activates arousal pathways in your brain

KI is a senior clinical academic in liaison psychiatry specialising in diabetes and obesity

Starting July 1, 2026, the Centers for Medicare & Medicaid Services (CMS) is launching the Medicare GLP-1 Bridge, a short-term program that gives eligible Medicare Part D beneficiaries access to certain GLP-1 weight loss medications for a $50 copay per month

Telogen effluvium is a condition that pushes an abnormal amount of hair follicles into the telogen phase, leading to more shedding than usual